Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer
Authors
Keywords
-
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-17
DOI
10.1007/s12253-020-00873-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
- (2019) Vincenzo Carafa et al. Frontiers in Pharmacology
- Sirtuin 6 plays an oncogenic role and induces cell autophagy in esophageal cancer cells
- (2017) Nan Huang et al. TUMOR BIOLOGY
- The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis
- (2017) Changwen Wang et al. Oncotarget
- Dual SIRT1 expression patterns strongly suggests its bivalent role in human breast cancer
- (2017) Khaldoun Rifaï et al. Oncotarget
- SIRT6 Suppresses Cancer Stem-like Capacity in Tumors with PI3K Activation Independently of Its Deacetylase Activity
- (2017) Rafael M. Ioris et al. Cell Reports
- Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease
- (2016) Aneesa Ansari et al. AGING CELL
- CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients
- (2016) Jun Sang Bae et al. AMERICAN JOURNAL OF PATHOLOGY
- High-throughput screening of Sirtuin family of genes in breast cancer
- (2016) Mehri Igci et al. GENE
- Expression of FOXM1 and related proteins in breast cancer molecular subtypes
- (2016) Jeong-Ju Lee et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- SIRT3 Silencing Sensitizes Breast Cancer Cells to Cytotoxic Treatments Through an Increment in ROS Production
- (2016) Margalida Torrens-Mas et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Role of SIRT1 in Cancer
- (2015) Melissa J. Wilking et al. AMERICAN JOURNAL OF PATHOLOGY
- Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer
- (2015) Soo Young Chung et al. CLINICAL & EXPERIMENTAL METASTASIS
- Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype
- (2015) Yul Ri Chung et al. HUMAN PATHOLOGY
- Sirtuins in Cancer: a Balancing Act between Genome Stability and Metabolism
- (2015) Seung Min Jeong et al. MOLECULES AND CELLS
- SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer
- (2015) Min-Sun Jin et al. TUMOR BIOLOGY
- SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer
- (2015) M F Santolla et al. Cell Death & Disease
- Targeting Mutant p53 by a SIRT1 Activator YK-3-237 Inhibits the Proliferation of Triple-Negative Breast Cancer Cells
- (2015) Yong Weon Yi et al. Oncotarget
- Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a
- (2015) Shun Zhang et al. Scientific Reports
- The SIRT 3 Expression Profile is Associated with Pathological and Clinical Outcomes in Human Breast Cancer Patients
- (2014) Shaozhong He et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Promoter Methylation Status and mRNA Expression Levels of CTCF and SIRT6 in Sporadic Breast Cancer
- (2014) Da Wang et al. DNA AND CELL BIOLOGY
- Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancer
- (2014) Mohamed Mokhtar Desouki et al. HUMAN PATHOLOGY
- Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer
- (2014) Yu-Wen Cao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer
- (2014) U. Thirumurthi et al. Science Signaling
- SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer
- (2013) Mattaka Khongkow et al. CARCINOGENESIS
- SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
- (2013) Petra Simic et al. Cell Reports
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
- (2012) Chu-Xia Deng International Journal of Biological Sciences
- Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer
- (2012) Minqing Wu et al. MEDICAL ONCOLOGY
- SIRT1 Is Essential for Oncogenic Signaling by Estrogen/Estrogen Receptor in Breast Cancer
- (2011) S. Elangovan et al. CANCER RESEARCH
- A c-Myc–SIRT1 feedback loop regulates cell growth and transformation
- (2009) Jian Yuan et al. JOURNAL OF CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started